Le Lézard
Classé dans : Santé
Sujets : Sondages, Opinions et Recheches, Femme, Nouvelles africaines et américaines

Dr. Sanusi Umar Invents New Hair Restoration Tools for FUE for Afro-Textured Curly Hair - Plastic and Reconstructive Surgery Journal (PRS-Global Open)


LOS ANGELES, Oct. 26, 2016 /PRNewswire/ -- For years, individuals of African descent seeking linear scar free follicular unit extraction (FUE) hair transplants have to undergo pre-testing only to be turned away by hair transplant surgeons using the traditional methods. The hair graft damage rate for FUE on Afro-textured hair (tight curly hair, texture, and tissue characteristics) can be as high as 80%. Thus many hair restoration surgeons offer individuals of African descent only hair transplant methods that leave a linear scar, until now.

In a new study published in the PRS - Global Open, Dr. Sanusi Umar advances FUE for African-Mixed Patients. With his patented UGraft® Revolution tool, the UPunch Curltm, the study participants experienced 100% success. Most patients demonstrated graft damage rate of less than 5%. The finding suggests that using this novel method, no pre-testing is required prior to FUE hair transplant surgery.

The UPunch Curltm accommodates the curliness of the hair and was compared to conventional rotary punch tools used in FUE. The superior graft rates observed with the UPunch Curltm are attributed to its unique design.

Dr. Umar notes, "Patients with tightly curled hair are not a homogenous group. This breakthrough points the way to a universal approach in FUE for people with tightly curled hair regardless of their Geo-ethnic background."

Currently UGraft and UPunch Curl treatments are only available from the inventor Dr. Sanusi Umar, who also plans to make the equipment and necessary training available to other hair restoration surgeons. For more information refer to https://www.dru.com

Plastic and Reconstructive Surgery?Global Open (PRS Global Open) is an open access, peer reviewed, international journal focusing on global plastic and reconstructive surgery.

Sanusi Umar, MD, FAAD, FASDS is an internationally recognized surgeon with board certification by the American Board of Dermatology, a Fellow of the American Society of Dermatologic Surgery, and Fellow of the American Academy of Dermatology. An associate faculty member at the David Geffen School of Medicine at the University of California at Los Angeles (UCLA), Dr. Umar is a well-published academic pioneer in the field of hair transplant surgery and a member of the International Society of Hair Restoration Surgery (ISHRS). His research has been published in multiple journals, including Journal of the American Medical Association - JAMA Dermatology, Aesthetic Surgery Journal and Dermatologic Surgery.

Contact:
Maureen O'Crean
310-567-1500
[email protected]

Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
Sanusi Umar, MD
ProfNet - http://www.profnetconnect.com/sanusiumar


Ces communiqués peuvent vous intéresser aussi

à 03:53
Collaboration stratégique pour tirer parti de l'héritage de leadership dans les maladies respiratoires de Chiesi et de l'expertise de Gossamer Bio en matière de développement pour l'hypertension pulmonaire.Gossamer recevra un paiement de...

à 03:39
mAbxience, un groupe détenu majoritairement par Fresenius Kabi et partiellement par Insud Pharma, a le plaisir d'annoncer la nomination de Jurgen Van Broeck au poste de président-directeur général. Jurgen, qui occupait le poste de directeur...

9 mai 2024
Field Medical,tm Inc., pionnier de la technologie d'ablation par cathéter cardiaque à champ pulsé, a annoncé aujourd'hui le...

9 mai 2024
5N Plus inc. (« 5N Plus » ou la « Société ») , chef de file de la production de semiconducteurs spécialisés et de matériaux de haute performance spécialisés à l'échelle mondiale, a annoncé que les candidats mentionnés dans la circulaire de...

9 mai 2024
RQM+, l'importante société internationale medtech de recherche contractuelle (CRO), a annoncé aujourd'hui la nomination de John Potthoff, Ph.D. en tant que nouveau PDG. Cette transition intervient tandis que l'ex-PDG, Margaret Keegan, a annoncé son...

9 mai 2024
Theratechnologies Inc. (« Theratechnologies » ou la « Société ») , une société biopharmaceutique axée sur le développement et la commercialisation de traitements innovateurs, a rapporté les résultats du vote lors de son assemblée annuelle des...



Communiqué envoyé le et diffusé par :